Assessment of Micafungin Dosage Regimens in Patients with Cancer Using Pharmacokinetic/Pharmacodynamic Modeling and Monte Carlo Simulation
Micafungin is widely used for invasive candidiasis, especially in critically ill patients and those with cancer, and for empirical antifungal therapy in patients with neutropenic fever. This is the first study to investigate the pharmacokinetics and disposition parameters of micafungin in patients w...
Saved in:
Main Authors: | Saeed Alqahtani (Author), Asma Alfarhan (Author), Abdullah Alsultan (Author), Emad Alsarhani (Author), Abdulaziz Alsubaie (Author), Yousif Asiri (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of Vancomycin in Healthy Korean Volunteers and Monte Carlo Simulations to Explore Optimal Dosage Regimens in Patients with Normal Renal Function
by: Yong Kyun Kim, et al.
Published: (2024) -
Clinical pharmacokinetics of capecitabine and its metabolites in colorectal cancer patients
by: Saeed Alqahtani, et al.
Published: (2022) -
Evaluation of pharmacokinetic pharmacodynamic target attainment of meropenem in pediatric patients
by: Abdullah Alsultan, et al.
Published: (2024) -
Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients
by: Xiping Li, et al.
Published: (2024) -
The recommended dosage regimen for caspofungin in patients with higher body weight or hypoalbuminaemia will result in low exposure: Five years of data based on a population pharmacokinetic model and Monte-Carlo simulations
by: Qianting Yang, et al.
Published: (2022)